TEVAPHARMIND SP ADR (NASDAQ:TEVA)

View All ReportsStreetInsider.com Reports on TEVA

Nov 20, 2009 11:43 AM Abbott (ABT) sues Teva (TEVA) over its drug for kidney patients, Zemplar

Nov 17, 2009 07:20 AM Merriman Curhan Ford Initiates Coverage on Antares Pharma (AIS) with a Buy; Cutting Edge Drug Delivery Business

Nov 10, 2009 04:28 PM Teva Pharma (TEVA) Gets Final U.S. FDA Approval for Generic Prevacid

Nov 10, 2009 10:07 AM Teva Pharma (TEVA) Announces Generic Version of Prevacid Does Not Infringe on Patents

Nov 10, 2009 07:20 AM Teva Pharma (TEVA) Seeks to Amend Existing Complaint Against Momenta Pharma over Copaxone Patent Infringement

View All Press ReleasesCompany Press Releases on TEVA

Nov 10, 2009 04:17PM Teva Receives Final Approval for Generic Prevacid(R) Delayed-Release Capsules

Nov 10, 2009 09:46AM Teva Receives Favorable Court Decision Regarding Generic Prevacid(R) SoluTab

Nov 10, 2009 02:01AM Teva Files Amended Complaint Against Momenta/Sandoz to Include Infringement of Three COPAXONE(R)-Related Patents

Nov 4, 2009 06:50AM Trading Outlook for Novavax Inc. Issued by InvestorSoup.com

Nov 3, 2009 03:35PM Teva Introduces Fexofenadine HCl and Pseudoephedrine HCl Extended-Release Tablets; An Alternative to Allegra-D(R) 12 Hour Tablets

StreetInsider Reports on TEVA by Category

• Analyst Ratings
• Mergers and Acquisitions
• Earnings
• Guidance
• Stock Buybacks
• Dividends
• Retail Sales
• Management Changes
• Insider Trades
• View More Categories

View All BlogsBlogs on TEVA

Nov 16, 2009 10:33 AM Santarus, Depomed Poised to Gain from Anticipated Sales of Glumetza

Nov 16, 2009 08:39 AM H&Q Healthcare Investors Closed-End Fund Decently Valued

Nov 9, 2009 07:29 AM Bionovo: Challenges Ahead, But Poised to Move Higher

Nov 8, 2009 06:35 AM Cephalon's Upside and Downside

Nov 4, 2009 04:16 PM Teva Reports Strong Third Quarter

View All FilingsSEC Filings on TEVA

Nov 10, 2009 08:48AM Form 6-K TEVA PHARMACEUTICAL INDU For: Apr 01

Nov 5, 2009 11:16AM Form 6-K TEVA PHARMACEUTICAL INDU For: Apr 01

Nov 4, 2009 08:09AM Form 6-K TEVA PHARMACEUTICAL INDU For: Apr 01

Nov 3, 2009 03:07PM Form 6-K TEVA PHARMACEUTICAL INDU For: Nov 03

Nov 3, 2009 08:16AM Form 6-K TEVA PHARMACEUTICAL INDU For: Nov 03

View All Comments Comments on recent TEVA articles

ANDREW OLIVER SATCHELL
on Nov 13, 2009
at 03:55 PM ANDREW OLIVER SATCHELL EXCELLENT
Article: Trading Radar for 11/03: UBS (UBS), Yamana Gold (AUY), Archer-Daniels (ADM), Royal Caribbean (RCL), Marathon (MRO) Report

Iki
on Sep 2, 2009
at 05:15 PM $10 is under esstimation !! Would like to emphsize that the holders can easily get more than $1B for FDA approved company, while $1B represent $13 of 76MM outstanding stocks. Profesionals can tell that the holder will not give up the company for much more...
Article: Hapoalim Securities Initiates Coverage on Protalix BioTherapeutics (PLX) with an Outperform; Attractive Entry Point

khalil
on Jul 24, 2009
at 09:29 AM atripla stop letting people die because a patent stops affordable drugs. healthcare is a right not a privilege as it is in Amerika.
Article: Gilead Sciences (GILD) Receives Notification of ANDA Filing for Atripla by Teva Pharma (TEVA)

Ross D
on Jul 4, 2009
at 05:25 PM what is this? ais at $25.12??? is this for real? not even funny if not!
Article: Teva (TEVA) and Antares (AIS) Announce FDA Approval of Needle-Free Injector for Tev-Tropin(R)

Thor
on Jan 2, 2009
at 03:04 PM Despite Lehman failure... Hats off to the Wall Street gurus who pulled off deals despite the carnage for example Teva's successful takeover of Barr was represented by Lehman until the venerable finance house went belly up. Nevertheless the deal close on time.
Article: Top 15 For 2008 (No. 14): M&A Wreckage

Comments on TEVA

No comments are currently available.

Name

Subject

Body

Verification can't see the text?
click here to refresh the image.
what's this?